Financing type: at-the-market prospectus offering
Gross proceeds: $11,261,931 (U.S.) in the quarter ended June 30, 2026, on the New York Stock Exchange
Offering: 3,139,330 common listed shares sold on the NYSE
Offering price: an average price of $3.59 (U.S.) per listed share on the NYSE
Disclosure: Refer to the new base shelf prospectus dated July 30, 2025, and the company's news releases dated Aug. 8, 2025, Oct. 3, 2025, Jan. 9, 2026, April 10, 2026, and July 3, 2026.
© 2026 Canjex Publishing Ltd. All rights reserved.